THERATECHNOLOGIES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.8 CAD | 0.00% |
|
-0.55% | -15.89% |
Chart calendar Theratechnologies Inc.
1af828e420bb2bc0e163a91cdafa7ad.3mWkflEhNsplJeYhVpWB2SVhMqxMVJWL-NmLIwTUDfE.sFHtUwhXdKcUFqNnBKbethNQetx8Du_miJ_JRzGmQJmKEeAnEBYbgFxnkQ~df229fb05bbb455b05e07d23f60f00b7
Upcoming events on Theratechnologies Inc.
Past events on Theratechnologies Inc.
| 2024-04-17 10:00 am | Bloom Burton & Co. Healthcare Investor Conference |
| 2024-04-10 08:30 am | Q1 2024 Earnings Call |
| 2024-04-10 07:30 am | Q1 2024 Earnings Release |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract Number : 3717 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract Number : 2071 |
| 2024-02-21 08:30 am | Q4 2023 Earnings Call |
| 2024-02-21 07:30 am | Q4 2023 Earnings Release |
| 2023-09-27 08:00 am | Cantor Global Healthcare Conference |
| 2023-09-26 08:30 am | Q3 2023 Earnings Call |
| 2023-09-26 07:30 am | Q3 2023 Earnings Release |
| 2023-09-11 12:00 am | H.C. Wainwright Global Investment Conference |
| 2023-07-30 | Reverse Split: 1 of 4 |
| 2023-07-12 08:30 am | Q2 2023 Earnings Call |
| 2023-07-12 07:30 am | Q2 2023 Earnings Release |
| 2023-06-13 10:00 am | Sudocetaxel Zendusortide Phase 1 Approval Call |
| 2023-06-03 09:00 am | American Society of Clinical Oncology Conference - Abstract number : 3089 |
| 2023-05-09 10:00 am | Annual General Meeting |
| 2023-04-25 08:30 am | Bloom Burton & Co Healthcare Investor Conference |
| 2023-04-18 09:00 am | American Association for Cancer Research Meeting - Abstract No: 4493 |
| 2023-04-18 09:00 am | American Association for Cancer Research Meeting - Abstract No: 4499 |
Annual results
| Fiscal Period | November | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 84,0 83,4 0.75% | 82,7 83,9 -1.42% | 89,7 87,6 2.49% | 109 109 0.04% | 110 113 -1.84% | 120 |
|
EBITDA Million CAD | Released Forecast Spread | 0,43 8,94 -95.2% | -8,88 -8,73 -1.63% | -18,7 -6,83 -174.52% | -32,0 -35,0 8.62% | -3,94 -8,51 53.73% | 19,2 |
|
EBIT Million CAD | Released Forecast Spread | -11,3 -6,11 -85.1% | -22,5 -23,6 4.66% | -32,4 -29,4 -10.16% | -54,2 -54,0 -0.34% | -14,4 -27,2 47.18% | 8,01 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -16,6 -4,37 -279.97% | -28,4 -24,7 -15.01% | -40,7 -34,1 -19.18% | -63,6 -62,2 -2.25% | -31,8 -40,2 20.94% | -7,00 |
|
Net income Million CAD | Released Forecast Spread | -16,6 -7,55 -120.06% | -28,4 -24,7 -15.01% | -40,8 -28,9 -40.85% | -64,2 -63,5 -0.98% | -32,4 -38,8 16.64% | -6,68 |
|
EPS CAD | Released Forecast Spread | -0,85 -0,38 -121.47% | -1,50 -1,11 -35.54% | -1,75 -1,29 -35.91% | -2,72 -2,57 -6% | -1,23 -1,20 -2.09% | -0,16 |
| Announcement Date | 25/02/20 | 25/02/21 | 24/02/22 | 28/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | November | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 23,4 27,2 -14.06% | 25,0 26,2 -4.55% | 28,7 28,0 2.43% | 29,1 29,1 0.07% | 26,8 29,2 -8.08% | 23,3 29,3 -20.65% | 28,1 28,2 -0.38% | 31,7 31,5 0.76% | 22,1 26,2 -15.84% | 29,8 | 31,1 | 35,3 |
|
EBITDA Million CAD | Released Forecast Spread | -15,2 -8,53 -77.75% | -5,24 0,00 -128427.7% | -8,09 -1,58 -413.17% | 2,91 -3,84 175.69% | 6,70 1,92 248.46% | -0,34 -0,24 -41.92% | 2,67 | 5,72 | 9,55 | |||
|
EBIT Million CAD | Released Forecast Spread | -9,74 -7,73 -26% | -27,2 -10,2 -167.46% | -7,61 -19,7 61.27% | -7,75 -7,74 -0.16% | -7,29 -4,83 -50.9% | -10,5 -5,14 -105.18% | 0,07 -7,07 101.03% | 3,61 -9,07 139.79% | -3,05 -2,93 -4.35% | 2,40 | 3,63 | 5,13 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -11,4 -8,74 -29.94% | -29,3 -11,3 -158.22% | -10,2 -20,7 50.63% | -10,6 -9,38 -12.74% | -13,9 -6,90 -101.97% | -13,1 -6,68 -96.45% | -0,84 -9,71 91.38% | -3,62 -11,8 69.32% | -5,94 -6,58 9.77% | -2,12 | -0,23 | 1,13 |
|
Net income Million CAD | Released Forecast Spread | -11,4 -8,74 -30.33% | -29,5 -11,3 -159.61% | -10,4 -20,7 49.62% | -10,8 -9,38 -14.81% | -14,1 -6,90 -103.84% | -13,3 -6,63 -100.29% | -1,01 -9,67 89.57% | -3,72 -11,5 67.49% | -6,09 -6,58 7.5% | -2,16 | -0,51 | 0,59 |
|
EPS CAD | Released Forecast Spread | -0,45 -0,36 -27.49% | -1,26 -0,49 -157.43% | -0,44 -0,65 32.09% | -0,49 -0,40 -23.27% | -0,59 -0,27 -117.56% | -0,53 -0,27 -98.55% | -0,04 -0,39 89.61% | -0,04 -0,43 90.55% | -0,14 -0,19 28.21% | -0,05 | -0,02 | 0,00 |
| Announcement Date | 13/04/22 | 14/07/22 | 13/10/22 | 28/02/23 | 12/04/23 | 12/07/23 | 26/09/23 | 21/02/24 | 10/04/24 | - | - | - |
More events
Past sector events for Theratechnologies Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TH Stock
- Calendar Theratechnologies Inc.
